1995
DOI: 10.1128/cmr.8.4.479
|View full text |Cite
|
Sign up to set email alerts
|

Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci

Abstract: Several new genera and species of gram-positive, catalase-negative cocci that can cause infections in humans have been described. Although these bacteria were isolated in the clinical laboratory, they were considered nonpathogenic culture contaminants and were not thought to be the cause of any diseases. Isolation of pure cultures of these bacteria from normally sterile sites has led to the conclusion that these bacteria can be an infrequent cause of infection. This review describes the new bacteria and the pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
159
0
6

Year Published

2007
2007
2014
2014

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 368 publications
(171 citation statements)
references
References 154 publications
0
159
0
6
Order By: Relevance
“…They may cause infections in individuals debilitated as a result of trauma or underlying disease (Mastro et al, 1990;Facklam & Elliot, 1995;Sarma & Mohanty, 1998;Barton et al, 2001). Some strains are resistant to vancomycin and teicoplanin (Swenson et al, 1990;Tankovic et al, 1993;Ammor et al, 2007;Haakensen et al, 2009), which may give them a competitive advantage in medical care environments (Colman & Efstratiou, 1987;Ruoff et al, 1988;Golledge et al, 1990;Mastro et al, 1990;Swenson et al, 1990;Green et al, 1991).…”
Section: Health and Disease (Medical)mentioning
confidence: 99%
“…They may cause infections in individuals debilitated as a result of trauma or underlying disease (Mastro et al, 1990;Facklam & Elliot, 1995;Sarma & Mohanty, 1998;Barton et al, 2001). Some strains are resistant to vancomycin and teicoplanin (Swenson et al, 1990;Tankovic et al, 1993;Ammor et al, 2007;Haakensen et al, 2009), which may give them a competitive advantage in medical care environments (Colman & Efstratiou, 1987;Ruoff et al, 1988;Golledge et al, 1990;Mastro et al, 1990;Swenson et al, 1990;Green et al, 1991).…”
Section: Health and Disease (Medical)mentioning
confidence: 99%
“…lactis ATCC 19435, the isolate, however, utilized L-arabinose, sucrose, amygdalin, and D-xylose. On the basis of acid production from 49 carbohydrates, the isolate was tentatively identified as L. lactis [19]. The strain was further characterized by sequencing of its PCR-amplified 16S rRNA gene.…”
Section: Resultsmentioning
confidence: 99%
“…The bacteriocin-producing isolate was identified by its colony morphology, Gram-staining, and biochemical tests [18,19], as well as by 16S rRNA gene sequencing [20]. The isolate was examined for acid production from 49 compounds as sole carbon source using API 50 CH Test kit (BioMerieux, Crappone, France) according to the manufacturer's instructions.…”
Section: Identification Of Bacteriocin-producing Strainmentioning
confidence: 99%
“…The API 20 strep code was 5214450. Although we were not able to use DNA sequence analysis to confirm this diagnosis, we gave special attention to various biochemical tests to exclude other vancomycin-resistant streptococci, Pediococcus and lactobacilli, using the criteria published in the literature [9,10]: the present strain was pyrrolidonyl arylamidase negative and lacked the enzyme leucine aminopeptidase, whereas arabinose was positive. The strain was not able to hydrolyze arginine.…”
Section: Case Reportmentioning
confidence: 99%